HSP90B1 and ovarian carcinoma: It was recently found that CDDO-Me can also directly interact with Hsp90 and suppress its functions (1.25–2.5 μM; HO8910/ SKOV3 ovarian cancer cells (3-24 h)) [98], however, its effect on Grp94 activity had not been evaluated.